A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
New information may help speed development of a vaccine or treatment for dengue fever.
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.
Accessibility Tools